CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy
Increasing prevalence of diabetes mellitus worldwide has pushed the complex disease state to the foreground of biomedical research, especially concerning its multifaceted impacts on the cardiovascular system. Current therapies for diabetic cardiomyopathy have had a positive impact, but with diabetic...
Saved in:
Main Authors: | Christopher R. Veitch (Author), Amelia S. Power (Author), Jeffrey R. Erickson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of CaMKII Activation
by: Jeffrey R Erickson
Published: (2014) -
Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing
by: Michael Arzt, et al.
Published: (2022) -
CaMKII in Cardiac Health and Disease
by: Andrew G Edwards
Published: (2014) -
CaMKII Inhibitors: From Research Tools to Therapeutic Agents
by: Patricia ePellicena, et al.
Published: (2014) -
CaMKII regulation of cardiac K channels
by: Julian eMustroph, et al.
Published: (2014)